SLC5A2 and familial renal glucosuria: One prominent example is the development of blockbuster SGLT2 (encoded by SLC5A2) inhibitors for the treatment of diabetic hyperglycaemia, which was inspired by associations between SLC5A2 mutations and familial renal glucosuria (OMIM identifier 233100).